Yunli Zhou

1.0k citations
24 papers · 735 indexed · h-index 13
Topics
Cancer Cells and Metastasis (6 papers)Cancer, Hypoxia, and Metabolism (4 papers)Mitochondrial Function and Pathology (3 papers)
Partner nations
ChinaCanadaUnited States

In The Last Decade

Yunli Zhou

24 papers receiving 722 citations

Peers

Yunli Zhou
Comparison fields: 5 of 71
  • Molecular Biology 528
  • Cancer Research 277
  • Oncology 168
  • Cellular and Molecular Neuroscience 68
  • Pulmonary and Respiratory Medicine 67
Replace Baoguo Liu with:
Baoguo Liu China
Mahnaz Bonrouhi Germany
Cristina Nuevo‐Tapioles Spain
Dongrong Yang China
Javier Guerrero Chile
Tetsushi Saishoji Japan
Ming Hu China
G Strada Italy
Klaudia Polak United States
Mingming Fang China
Yunli Zhou relative to Baoguo Liu China Baoguo Liu's profile →
Citations per field
00.5×3.1×
Baoguo Liu · 1×
Citations per year

Countries citing papers authored by Yunli Zhou

Since Specialization
Citations

This map shows the geographic impact of Yunli Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunli Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunli Zhou more than expected).

Fields of papers citing papers by Yunli Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunli Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunli Zhou. The network helps show where Yunli Zhou may publish in the future.

Co-authorship network of co-authors of Yunli Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yunli Zhou. A scholar is included among the top collaborators of Yunli Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunli Zhou. Yunli Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 10
3 19
4 1
5 4
6 9
7 12
8 16
9 18
10 51
11 28
12
Enzyme Kinetic Assay to Measure the Activity of Tumor M2 Pyruvate Kinase in Breast Cancer Patients.
1
13 5
14 78
15 42
16 210
17 70
18 29
19 9
20 3

About Yunli Zhou

Yunli Zhou is a scholar working on Oncology, Cancer Research and Clinical Biochemistry, having authored 24 papers that have together received 735 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Cancer Research (277 citations), Clinical Biochemistry (60 citations) and Molecular Biology (528 citations). Yunli Zhou has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Man Yu, Ruifang Niu, Yurong Shi, Yi Yang, Xiyin Wei, Xishan Hao, Dong Dong, Ning Zhang, Liansheng Ning and Lufang Zhang. Their work appears in journals such as Life Sciences, Molecular Endocrinology and Cell Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026